A detailed history of Exodus Point Capital Management, LP transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 883,043 shares of TARS stock, worth $43.9 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
883,043
Previous 670,459 31.71%
Holding current value
$43.9 Million
Previous $18.2 Million 59.38%
% of portfolio
0.18%
Previous 0.12%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$21.54 - $34.6 $4.58 Million - $7.36 Million
212,584 Added 31.71%
883,043 $29 Million
Q2 2024

Aug 13, 2024

BUY
$25.17 - $38.73 $11.4 Million - $17.6 Million
454,501 Added 210.46%
670,459 $18.2 Million
Q1 2024

May 14, 2024

SELL
$19.61 - $39.22 $3.58 Million - $7.16 Million
-182,683 Reduced 45.83%
215,958 $7.85 Million
Q3 2023

Nov 09, 2023

BUY
$14.75 - $24.62 $3.01 Million - $5.02 Million
203,820 Added 104.62%
398,641 $7.08 Million
Q2 2023

Aug 10, 2023

BUY
$11.57 - $19.63 $2.25 Million - $3.82 Million
194,821 New
194,821 $3.52 Million

Others Institutions Holding TARS

About Tarsus Pharmaceuticals, Inc.


  • Ticker TARS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,658,500
  • Market Cap $1.32B
  • Description
  • Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...
More about TARS
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.